Cohort Study on the Effects of Aging in Acquired Brain Injury Patients
NCT ID: NCT05499806
Last Updated: 2022-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
800 participants
OBSERVATIONAL
2022-03-18
2024-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Long-term Consequences After Traumatic Brain Injury in the Elderly
NCT04074850
Coach Pilot Study: Assessing Cognitive Function and Related Small Vessel Disease Markers After Intracerebral Hemorrhage
NCT05499169
Prospective Memory Imaging
NCT01638884
The Impact of Traumatic Brain Injury in the Elderly
NCT04070092
Study of Iron Accumulation Measured in MRI in Non-pathological Aging
NCT04659824
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary objective:
Explore the prevalence of the ABI-effect, by mapping the participation level.
Secondary objective:
Substantiate the occurence of the ABI-effect, by mapping cognitive functions of patients and compare these to healthy controls.
Tertiary objective:
Gain insight in the need of care for patients, to enhance regular care after ABI.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acquired Brain Injury Patients
Questionnaire and, if the requirements are met, a neuropsychological assessment.
No interventions assigned to this group
Healthy volunteers
Questionnaire and, if the requirements are met, a neuropsychological assessment.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to complete questionnaires independently
Additionally, patients must also meet the following criteria:
* Age of acquiring the ABI ≧ 25 years \[Rationale: the brain is supposed to be fully developed at a maximum capacity
* ABI must be ≧ 5 years ago\] \[Rationale :time period regarded sufficient to have achieved a stable level of cognitive functioning and participation after an ABI\]
* ABI diagnosis at hospital admission with abnormalities at the brain-CT or MRI
* Independent regarding Activities of Daily Living
* Not living in a long-term care facility
Exclusion Criteria
* Accompanying disease with reduced life expectancy
* Neurological disease (including recurrent ABI for patients)
* Language barriers prohibiting and completion of Dutch questionnaires
* Alcohol or drug abuse
* Suspected neurodegenerative disease
50 Years
67 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ZonMw: The Netherlands Organisation for Health Research and Development
OTHER
University Medical Center Groningen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joukje van der Naalt
Prof. dr. J. van der Naalt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Isala klinieken
Zwolle, Overijssel, Netherlands
Revalidatiecentrum Heliomare Wijk aan Zee
Wijk aan Zee, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL79072.042.21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.